Improve the knowledge base on patient‐oriented KT research in diabetes and its related complications.

Develop strategic partnerships with different stakeholders to disseminate the work done by Diabetes Action Canada members.

To facilitate the support for new models of care that will result in better outcomes and better experience for individuals living with diabetes.

Co-Lead: France Légaré, Sophie Desroches

Co-Investigators:  Joyce Dogba, Monika Kastner, Helene Lee-Goselin, Lori McCallum, Monica Parry, Mary-Claude Tremblay, Holly Witteman, Catherine Yu

Project Coordinator: Annie Barbeau


Our Mission

The Knowledge Translation (KT) Enabling Program, under the co-leadership of Sophie Desroches and France Légaré, has established an integrated program with Diabetes Action Canada with the main objective to facilitate the application of research findings into healthcare practices. Our team supports members of Diabetes Action Canada for contributing to the science and practice on how to better move knowledge into practice.

Our projects, commitments and progress:

To date, the KT Enabling Group has initiated or assisted researchers in evaluating the potential to scale-up their successful evidence-based products.

Examples of our KT research programs and ongoing interactions are below:

  • Building capacity in KT through a scholarship program.  This program is for graduate students and postdoctoral fellows who are supervised by members of Diabetes Action Canada. This scholarship is in partnership with a pan‐Canadian consortium of knowledge translation scholars, KT Canada.  In 2017-18, 2 PhD students and 2 postdoctoral fellows supervised by members of our Network were awarded KT scholarships.  Awardees are enrolled in KT Canada monthly meetings where they are having the opportunity to learn from and connect with prominent names in KT research. Also, they will participate a formal KT research training at the KT Canada Summer Institute 2018, in Toronto.  Another round of this program is under consideration for academic year 2019-2020.
  • Conduct an environmental scan to create a comprehensive inventory on effective KT strategies on effective knowledge translation strategies for preventing diabetes complications that will inform different stakeholders about the current state of KT related products to patient-oriented research methods and evidence in diabetes.  The Research Program is also working collaboratively with our Patient Partners, to conduct an environmental scan of the KT tools available across Canada relevant to Diabetes Action Canada activities.   The goal is to create a ‘KT toolkit’ of existing evidence-based approaches in diabetes care for dissemination to physicians and health care professionals to standardize improved care. To add to our KT tool kit, please contact
  • The scalability assessment tool to allow different stakeholder and interest groups to evaluated the potential of an evidence practice to be scaled up. This tool was funded by CIHR, validated by the 12 community-based primary health care teams, and published in CMAJ in 2018.  This tool is also used by the Aging, Community and Population Health program as they assess the scalability of  their intervention.
  • Providing expertise for the Diabetes Action Canada ongoing network analysis and evaluation done collaboratively with Mathieu Ouimet and Valeria Rac.  This evaluation will take a scientific approach to measuring the interaction of Diabetes Action Canada as a research network and its  impact on decision makers, health professionals and patients.
  • Conduct a pilot study aiming to prepare for a real-world implementation of an inter-professional approach to shared decision making (SDM) in diabetes care and evaluate its potential to be scaled up.

We are dedicated to build synergy between our KT Enabling Group and other Diabetes Action Canada Programs

As an enabling research program, KT has accomplished the following to support the members of Diabetes Action Canada:

  • Assisted the Aging, Community and Population Health program with their successful CIHR PIHCI grant proposal and scaling their successful program of implementing home care with the elderly living with diabetes in Quebec and across Canada. This includes fostering relationships with Quebec practice-based research networks (PBRNs) to secure sites to scale their intervention and contributing to the scalability assessment.
  • Enabled recruitment of the 12 Université Laval PBRN sites to include Quebec-based primary care data from the Canadian Primary Care Sentinel Surveillance Network into our National Diabetes Repository. They fostered linkages with PULSAR, the université Laval big data main initiative.
  • Collaborated with the Diabetic Retinopathy program, Patient Engagement program and the Ottawa Health Research Institute to identify and understand barriers preventing persons in vulnerable populations, e.g. New Immigrants, from receiving diabetic retinopathy screening. These results  will inform  patient-oriented interventions to address the barriers experience by high-risk groups and identify enablers to overcome these barriers.
  • Partners with the Patient Engagement program to ensure operational management of their program and integration of patient engagement activities in the KT program.
  • Collaborates with the Sex and Gender program to develop effective KT strategies that include sex and gender considerations in diabetes-related patient-oriented research and best practices (e.g. Diabetes Canada guidelines of 2018). This will enable the goals of both programs to build capacity in their respective areas.
  • Develop partnerships with other SPOR networks to increase the impact of the DAC network (eg. with other SPOR networks and initiatives such as PIHCI, Can‐SOLVE CKD, SPOR Evidence Alliance, KT component of the SPOR SUPPORT units, diverse stakeholders such as Réseau‐1 Québec (FRQS primary care PBRN networks), Patient Advisors Network, Diabetes Canada, Diabète Québec, INESSS)

Stay updated with News and Events